Healthtech Solutions Inc.’s (HLTT) Cloud-Based S
Post# of 26
- HLTT’s Mediscan cloud-based SaaS software transforms 2D analog ultrasound images into 3D HD quantifiable formats
- Growing list of Mediscan applications include use by primary care physicians, specialists, support staff, sports trainers, EMS personnel and technicians in isolation wards and emergency rooms
- Mediscan to be offered as cloud-based medical software-as-a-service (“SaaS”)
- Patents filed with United States Patent and Trademark Office for System Method, Apparatus, and Computer Program Product for Ultrasonic Clinical Decision Support
Primary care physicians, specialists, sports professionals and emergency medical services personnel can now produce high-quality 3D digital medical images with an analog ultrasound machine through Healthtech Solutions’ (OTC: HLTT) Mediscan cloud-based software.
HLTT’s Mediscan software generates 3D medical images of any body part that ultrasound technology can access, including vital organs such as the heart, lungs, kidneys, gallbladder and spleen, along with tendons and skin. The technique reconstructs analog two-dimensional grayscale visual images into digital three-dimensional, high-definition quantifiable formats in roughly one minute that can be viewed on the technician’s desktop computer, monitor, tablet or mobile phone.
Mediscan has the potential to bridge the image quality gap between ultrasound technology and the significantly costlier and resource-intensive MRI, CT, and X-ray imaging techniques. The technology will empower medical professionals by providing them with data-driven metrics that enhance decision-making at the point of service. Office-based medical physicians and sports therapists will leverage the technology onsite along with emergency medical services professionals that work on-call in remote areas. Besides providing analytics to analyze the patient’s pathology or trauma, Mediscan software will facilitate treatment option decisions, help medical professionals monitor ongoing progress or regress, and assist with document compliance to ensure that all assessments meet required protocols and procedures.
HLTT plans to deploy the service as a medical software-as-a-service (“SaaS”) – a model used widely in the healthcare sector whereby software is licensed on a subscription basis through a centrally hosted cloud-based vendor. Along with its use for clinical information systems, SaaS is gaining software market share in supply chain management, billing services and revenue cycle management. Favored by organizations of all sizes, SaaS is ideal for smaller operations looking to leverage world-class infrastructure without investing in external hardware or IT services.
The United States medical imaging market size was recently valued at $134 billion (https://nnw.fm/1eW20) and is expected to continue growing as part of the healthcare industry’s digital transformation. As a result of the technological shift, HLTT’s management team sees a promising opportunity for Mediscan to distribute its technology and has filed patents with the United States Patent and Trademark Office through its Mediscan subsidiary for a System Method, Apparatus, and Computer Program Product for Ultrasonic Clinical Decision Support.
HLTT’s mission is to produce cost-effective, high-quality 3D imaging software accessible to healthcare providers of all sizes and types across the entire healthcare industry. A growing list of use cases, coupled with increased demand for detailed medical imaging, provides a promising opportunity for the company to develop and distribute its medical imaging solutions to physicians, technicians and therapists across a wide range of specialties in the healthcare space.
For more information, visit the company’s website at www.MyMediScan.com.
NOTE TO INVESTORS: The latest news and updates relating to HLTT are available in the company’s newsroom at https://nnw.fm/HLTT
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer